667, L.P., Director, 10% Owner at GENOMIC HEALTH INC (GHDX), sold 55,623 shares at $74.88 ($4.1M) on 2018-12-11, disclosed to the SEC on 2018-12-12.
Open-market sale of $4.1M GHDX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $71.81 | 1,939 | $139K | 3.4% |
| 2 | $71.81 | 12,627 | $907K | 22.0% |
| 3 | $74.88 | 921 | $69K | 1.7% |
| 4 | $74.88 | 5,342 | $400K | 9.7% |
| 5 | $74.88 | 34,794 | $2.6M | 63.2% |
| Total | $74.08 avg | 55,623 |
| $4.1M |
| 100% |
| Filing → |
| MDGL | BUY | 2023-12-14 | $14.7M | — | Filing → |
| ACAD | BUY | 2023-05-24 | $45.4M | — | Filing → |
| TCRX | BUY | 2022-05-12 | $4.8M | — | Filing → |